NUTR CANCER 润色咨询

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

出版年份:1978 年文章数:2788 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:药理<br>经验分享:09 January 2023<br>Manuscript Resubmitted<br>09 January 2023<br>With Journal Administrator<br>PEER REVIEW<br>28 December 2022<br>Ready to Revise<br>29 December 2022<br>Resubmission Incomplete<br>29 December 2022<br>Revised Manuscript Submitted<br>18 January 2023<br>With Editor<br>16 February 2023<br>Out for Review<br>21 February 2023<br>Decision Pending<br>24 February 2023<br>Revision Required<br>14 March 2023<br>Revision Incomplete<br>14 March 2023<br>Revised Manuscript Submitted<br>14 March 2023<br>With Journal Administrator<br>16 March 2023<br>With Editor<br>16 March 2023<br>Out for Review<br>06 April 2023<br>Decision Pending<br>09 April 2023<br>Revision Required<br>11 April 2023<br>Revision Incomplete<br>11 April 2023<br>Revised Manuscript Submitted<br>11 April 2023<br>With Journal Administrator<br>19 April 2023<br>Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor<br>14 June 2023 Out for review<br>02 August 2023 Decision Pending<br>02 August 2023 Rejected<br>等了很久,等了这个结果超级难过,本来对这个期刊抱有很大的希望,现在都开始自我怀疑了,以上的时间进度希望给大家一个参考,我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢,着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:20 August 2022 Submission Created<br>21 August 2022 Manuscript Submitted<br>21 August 2022 With Journal Administrator<br>22 August 2022 Submission Returned to Author<br>22 August 2022 Manuscript Resubmitted<br>22 August 2022 With Journal Administrator<br>24 August 2022 Ready to Revise<br>31 August 2022 Revised Manuscript Submitted<br>02 September 2022 Submission Returned to Author<br>03 September 2022 Manuscript Resubmitted<br>03 September 2022 With Journal Administrator<br>21 September 2022 With Editor<br>20 October 2022 Out for Review<br>20 October 2022 Decision Pending<br>26 October 2022 Revision Required<br>24 November 2022 Revised Manuscript Submitted<br>24 November 2022 With Journal Administrator<br>28 November 2022 With Editor<br>29 November 2022 Out for Review<br>07 December 2022 Decision Pending<br>07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向:肿瘤;meta-analysis<br>经验分享:我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回,我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了,但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:一审三个月,没什么大问题,拖了一个月返回去,二审小修,两天返回,不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;营养<br>经验分享:with editor 一个月都已经联系编辑撤回了,等周一编辑上班回复前突然送审了就等着了,20天一审结束返修,2个审稿人都很nice,4天修回。二审一个月,刚接收!夸赞一下这个宝藏杂志,挺好的。编辑都很nice,邮件回复都很及时,沟通很愉快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224238, encodeId=b864122423872, content=审稿速度:6.0 | 投稿命中率:50.0 | 影响因子:2.9<br>经验分享:肿瘤,换主编了,审稿严格起来了,需要有一定质量的文章,审了7个月,审稿时间太长了,杯具, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Fri Jun 03 12:57:39 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2023-09-21 ms898308530249 来自四川省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:药理
    经验分享:09 January 2023
    Manuscript Resubmitted
    09 January 2023
    With Journal Administrator
    PEER REVIEW
    28 December 2022
    Ready to Revise
    29 December 2022
    Resubmission Incomplete
    29 December 2022
    Revised Manuscript Submitted
    18 January 2023
    With Editor
    16 February 2023
    Out for Review
    21 February 2023
    Decision Pending
    24 February 2023
    Revision Required
    14 March 2023
    Revision Incomplete
    14 March 2023
    Revised Manuscript Submitted
    14 March 2023
    With Journal Administrator
    16 March 2023
    With Editor
    16 March 2023
    Out for Review
    06 April 2023
    Decision Pending
    09 April 2023
    Revision Required
    11 April 2023
    Revision Incomplete
    11 April 2023
    Revised Manuscript Submitted
    11 April 2023
    With Journal Administrator
    19 April 2023
    Accepted

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:药理<br>经验分享:09 January 2023<br>Manuscript Resubmitted<br>09 January 2023<br>With Journal Administrator<br>PEER REVIEW<br>28 December 2022<br>Ready to Revise<br>29 December 2022<br>Resubmission Incomplete<br>29 December 2022<br>Revised Manuscript Submitted<br>18 January 2023<br>With Editor<br>16 February 2023<br>Out for Review<br>21 February 2023<br>Decision Pending<br>24 February 2023<br>Revision Required<br>14 March 2023<br>Revision Incomplete<br>14 March 2023<br>Revised Manuscript Submitted<br>14 March 2023<br>With Journal Administrator<br>16 March 2023<br>With Editor<br>16 March 2023<br>Out for Review<br>06 April 2023<br>Decision Pending<br>09 April 2023<br>Revision Required<br>11 April 2023<br>Revision Incomplete<br>11 April 2023<br>Revised Manuscript Submitted<br>11 April 2023<br>With Journal Administrator<br>19 April 2023<br>Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor<br>14 June 2023 Out for review<br>02 August 2023 Decision Pending<br>02 August 2023 Rejected<br>等了很久,等了这个结果超级难过,本来对这个期刊抱有很大的希望,现在都开始自我怀疑了,以上的时间进度希望给大家一个参考,我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢,着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:20 August 2022 Submission Created<br>21 August 2022 Manuscript Submitted<br>21 August 2022 With Journal Administrator<br>22 August 2022 Submission Returned to Author<br>22 August 2022 Manuscript Resubmitted<br>22 August 2022 With Journal Administrator<br>24 August 2022 Ready to Revise<br>31 August 2022 Revised Manuscript Submitted<br>02 September 2022 Submission Returned to Author<br>03 September 2022 Manuscript Resubmitted<br>03 September 2022 With Journal Administrator<br>21 September 2022 With Editor<br>20 October 2022 Out for Review<br>20 October 2022 Decision Pending<br>26 October 2022 Revision Required<br>24 November 2022 Revised Manuscript Submitted<br>24 November 2022 With Journal Administrator<br>28 November 2022 With Editor<br>29 November 2022 Out for Review<br>07 December 2022 Decision Pending<br>07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向:肿瘤;meta-analysis<br>经验分享:我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回,我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了,但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:一审三个月,没什么大问题,拖了一个月返回去,二审小修,两天返回,不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;营养<br>经验分享:with editor 一个月都已经联系编辑撤回了,等周一编辑上班回复前突然送审了就等着了,20天一审结束返修,2个审稿人都很nice,4天修回。二审一个月,刚接收!夸赞一下这个宝藏杂志,挺好的。编辑都很nice,邮件回复都很及时,沟通很愉快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224238, encodeId=b864122423872, content=审稿速度:6.0 | 投稿命中率:50.0 | 影响因子:2.9<br>经验分享:肿瘤,换主编了,审稿严格起来了,需要有一定质量的文章,审了7个月,审稿时间太长了,杯具, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Fri Jun 03 12:57:39 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2023-08-03 ms4000001156703951 来自河南省

    11 May 2023 With Editor
    14 June 2023 Out for review
    02 August 2023 Decision Pending
    02 August 2023 Rejected
    等了很久,等了这个结果超级难过,本来对这个期刊抱有很大的希望,现在都开始自我怀疑了,以上的时间进度希望给大家一个参考,我投的meta

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:药理<br>经验分享:09 January 2023<br>Manuscript Resubmitted<br>09 January 2023<br>With Journal Administrator<br>PEER REVIEW<br>28 December 2022<br>Ready to Revise<br>29 December 2022<br>Resubmission Incomplete<br>29 December 2022<br>Revised Manuscript Submitted<br>18 January 2023<br>With Editor<br>16 February 2023<br>Out for Review<br>21 February 2023<br>Decision Pending<br>24 February 2023<br>Revision Required<br>14 March 2023<br>Revision Incomplete<br>14 March 2023<br>Revised Manuscript Submitted<br>14 March 2023<br>With Journal Administrator<br>16 March 2023<br>With Editor<br>16 March 2023<br>Out for Review<br>06 April 2023<br>Decision Pending<br>09 April 2023<br>Revision Required<br>11 April 2023<br>Revision Incomplete<br>11 April 2023<br>Revised Manuscript Submitted<br>11 April 2023<br>With Journal Administrator<br>19 April 2023<br>Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor<br>14 June 2023 Out for review<br>02 August 2023 Decision Pending<br>02 August 2023 Rejected<br>等了很久,等了这个结果超级难过,本来对这个期刊抱有很大的希望,现在都开始自我怀疑了,以上的时间进度希望给大家一个参考,我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢,着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:20 August 2022 Submission Created<br>21 August 2022 Manuscript Submitted<br>21 August 2022 With Journal Administrator<br>22 August 2022 Submission Returned to Author<br>22 August 2022 Manuscript Resubmitted<br>22 August 2022 With Journal Administrator<br>24 August 2022 Ready to Revise<br>31 August 2022 Revised Manuscript Submitted<br>02 September 2022 Submission Returned to Author<br>03 September 2022 Manuscript Resubmitted<br>03 September 2022 With Journal Administrator<br>21 September 2022 With Editor<br>20 October 2022 Out for Review<br>20 October 2022 Decision Pending<br>26 October 2022 Revision Required<br>24 November 2022 Revised Manuscript Submitted<br>24 November 2022 With Journal Administrator<br>28 November 2022 With Editor<br>29 November 2022 Out for Review<br>07 December 2022 Decision Pending<br>07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向:肿瘤;meta-analysis<br>经验分享:我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回,我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了,但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:一审三个月,没什么大问题,拖了一个月返回去,二审小修,两天返回,不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;营养<br>经验分享:with editor 一个月都已经联系编辑撤回了,等周一编辑上班回复前突然送审了就等着了,20天一审结束返修,2个审稿人都很nice,4天修回。二审一个月,刚接收!夸赞一下这个宝藏杂志,挺好的。编辑都很nice,邮件回复都很及时,沟通很愉快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224238, encodeId=b864122423872, content=审稿速度:6.0 | 投稿命中率:50.0 | 影响因子:2.9<br>经验分享:肿瘤,换主编了,审稿严格起来了,需要有一定质量的文章,审了7个月,审稿时间太长了,杯具, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Fri Jun 03 12:57:39 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2023-06-01 ms4000001156703951 来自河南省

    请问Out for Review多久会有消息呢,着急

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:药理<br>经验分享:09 January 2023<br>Manuscript Resubmitted<br>09 January 2023<br>With Journal Administrator<br>PEER REVIEW<br>28 December 2022<br>Ready to Revise<br>29 December 2022<br>Resubmission Incomplete<br>29 December 2022<br>Revised Manuscript Submitted<br>18 January 2023<br>With Editor<br>16 February 2023<br>Out for Review<br>21 February 2023<br>Decision Pending<br>24 February 2023<br>Revision Required<br>14 March 2023<br>Revision Incomplete<br>14 March 2023<br>Revised Manuscript Submitted<br>14 March 2023<br>With Journal Administrator<br>16 March 2023<br>With Editor<br>16 March 2023<br>Out for Review<br>06 April 2023<br>Decision Pending<br>09 April 2023<br>Revision Required<br>11 April 2023<br>Revision Incomplete<br>11 April 2023<br>Revised Manuscript Submitted<br>11 April 2023<br>With Journal Administrator<br>19 April 2023<br>Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor<br>14 June 2023 Out for review<br>02 August 2023 Decision Pending<br>02 August 2023 Rejected<br>等了很久,等了这个结果超级难过,本来对这个期刊抱有很大的希望,现在都开始自我怀疑了,以上的时间进度希望给大家一个参考,我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢,着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:20 August 2022 Submission Created<br>21 August 2022 Manuscript Submitted<br>21 August 2022 With Journal Administrator<br>22 August 2022 Submission Returned to Author<br>22 August 2022 Manuscript Resubmitted<br>22 August 2022 With Journal Administrator<br>24 August 2022 Ready to Revise<br>31 August 2022 Revised Manuscript Submitted<br>02 September 2022 Submission Returned to Author<br>03 September 2022 Manuscript Resubmitted<br>03 September 2022 With Journal Administrator<br>21 September 2022 With Editor<br>20 October 2022 Out for Review<br>20 October 2022 Decision Pending<br>26 October 2022 Revision Required<br>24 November 2022 Revised Manuscript Submitted<br>24 November 2022 With Journal Administrator<br>28 November 2022 With Editor<br>29 November 2022 Out for Review<br>07 December 2022 Decision Pending<br>07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向:肿瘤;meta-analysis<br>经验分享:我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回,我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了,但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:一审三个月,没什么大问题,拖了一个月返回去,二审小修,两天返回,不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;营养<br>经验分享:with editor 一个月都已经联系编辑撤回了,等周一编辑上班回复前突然送审了就等着了,20天一审结束返修,2个审稿人都很nice,4天修回。二审一个月,刚接收!夸赞一下这个宝藏杂志,挺好的。编辑都很nice,邮件回复都很及时,沟通很愉快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224238, encodeId=b864122423872, content=审稿速度:6.0 | 投稿命中率:50.0 | 影响因子:2.9<br>经验分享:肿瘤,换主编了,审稿严格起来了,需要有一定质量的文章,审了7个月,审稿时间太长了,杯具, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Fri Jun 03 12:57:39 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2023-07-03 ms4000001156703951 来自河南省

    请问meta类文章一般out for review多久会有消息呢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:药理<br>经验分享:09 January 2023<br>Manuscript Resubmitted<br>09 January 2023<br>With Journal Administrator<br>PEER REVIEW<br>28 December 2022<br>Ready to Revise<br>29 December 2022<br>Resubmission Incomplete<br>29 December 2022<br>Revised Manuscript Submitted<br>18 January 2023<br>With Editor<br>16 February 2023<br>Out for Review<br>21 February 2023<br>Decision Pending<br>24 February 2023<br>Revision Required<br>14 March 2023<br>Revision Incomplete<br>14 March 2023<br>Revised Manuscript Submitted<br>14 March 2023<br>With Journal Administrator<br>16 March 2023<br>With Editor<br>16 March 2023<br>Out for Review<br>06 April 2023<br>Decision Pending<br>09 April 2023<br>Revision Required<br>11 April 2023<br>Revision Incomplete<br>11 April 2023<br>Revised Manuscript Submitted<br>11 April 2023<br>With Journal Administrator<br>19 April 2023<br>Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor<br>14 June 2023 Out for review<br>02 August 2023 Decision Pending<br>02 August 2023 Rejected<br>等了很久,等了这个结果超级难过,本来对这个期刊抱有很大的希望,现在都开始自我怀疑了,以上的时间进度希望给大家一个参考,我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢,着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:20 August 2022 Submission Created<br>21 August 2022 Manuscript Submitted<br>21 August 2022 With Journal Administrator<br>22 August 2022 Submission Returned to Author<br>22 August 2022 Manuscript Resubmitted<br>22 August 2022 With Journal Administrator<br>24 August 2022 Ready to Revise<br>31 August 2022 Revised Manuscript Submitted<br>02 September 2022 Submission Returned to Author<br>03 September 2022 Manuscript Resubmitted<br>03 September 2022 With Journal Administrator<br>21 September 2022 With Editor<br>20 October 2022 Out for Review<br>20 October 2022 Decision Pending<br>26 October 2022 Revision Required<br>24 November 2022 Revised Manuscript Submitted<br>24 November 2022 With Journal Administrator<br>28 November 2022 With Editor<br>29 November 2022 Out for Review<br>07 December 2022 Decision Pending<br>07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向:肿瘤;meta-analysis<br>经验分享:我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回,我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了,但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:一审三个月,没什么大问题,拖了一个月返回去,二审小修,两天返回,不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;营养<br>经验分享:with editor 一个月都已经联系编辑撤回了,等周一编辑上班回复前突然送审了就等着了,20天一审结束返修,2个审稿人都很nice,4天修回。二审一个月,刚接收!夸赞一下这个宝藏杂志,挺好的。编辑都很nice,邮件回复都很及时,沟通很愉快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224238, encodeId=b864122423872, content=审稿速度:6.0 | 投稿命中率:50.0 | 影响因子:2.9<br>经验分享:肿瘤,换主编了,审稿严格起来了,需要有一定质量的文章,审了7个月,审稿时间太长了,杯具, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Fri Jun 03 12:57:39 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2022-12-09 ms1000002133818494 来自四川省

    审稿速度:6.0 | 投稿命中率:75.0
    经验分享:20 August 2022 Submission Created
    21 August 2022 Manuscript Submitted
    21 August 2022 With Journal Administrator
    22 August 2022 Submission Returned to Author
    22 August 2022 Manuscript Resubmitted
    22 August 2022 With Journal Administrator
    24 August 2022 Ready to Revise
    31 August 2022 Revised Manuscript Submitted
    02 September 2022 Submission Returned to Author
    03 September 2022 Manuscript Resubmitted
    03 September 2022 With Journal Administrator
    21 September 2022 With Editor
    20 October 2022 Out for Review
    20 October 2022 Decision Pending
    26 October 2022 Revision Required
    24 November 2022 Revised Manuscript Submitted
    24 November 2022 With Journal Administrator
    28 November 2022 With Editor
    29 November 2022 Out for Review
    07 December 2022 Decision Pending
    07 December 2022 Accepted

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:药理<br>经验分享:09 January 2023<br>Manuscript Resubmitted<br>09 January 2023<br>With Journal Administrator<br>PEER REVIEW<br>28 December 2022<br>Ready to Revise<br>29 December 2022<br>Resubmission Incomplete<br>29 December 2022<br>Revised Manuscript Submitted<br>18 January 2023<br>With Editor<br>16 February 2023<br>Out for Review<br>21 February 2023<br>Decision Pending<br>24 February 2023<br>Revision Required<br>14 March 2023<br>Revision Incomplete<br>14 March 2023<br>Revised Manuscript Submitted<br>14 March 2023<br>With Journal Administrator<br>16 March 2023<br>With Editor<br>16 March 2023<br>Out for Review<br>06 April 2023<br>Decision Pending<br>09 April 2023<br>Revision Required<br>11 April 2023<br>Revision Incomplete<br>11 April 2023<br>Revised Manuscript Submitted<br>11 April 2023<br>With Journal Administrator<br>19 April 2023<br>Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor<br>14 June 2023 Out for review<br>02 August 2023 Decision Pending<br>02 August 2023 Rejected<br>等了很久,等了这个结果超级难过,本来对这个期刊抱有很大的希望,现在都开始自我怀疑了,以上的时间进度希望给大家一个参考,我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢,着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:20 August 2022 Submission Created<br>21 August 2022 Manuscript Submitted<br>21 August 2022 With Journal Administrator<br>22 August 2022 Submission Returned to Author<br>22 August 2022 Manuscript Resubmitted<br>22 August 2022 With Journal Administrator<br>24 August 2022 Ready to Revise<br>31 August 2022 Revised Manuscript Submitted<br>02 September 2022 Submission Returned to Author<br>03 September 2022 Manuscript Resubmitted<br>03 September 2022 With Journal Administrator<br>21 September 2022 With Editor<br>20 October 2022 Out for Review<br>20 October 2022 Decision Pending<br>26 October 2022 Revision Required<br>24 November 2022 Revised Manuscript Submitted<br>24 November 2022 With Journal Administrator<br>28 November 2022 With Editor<br>29 November 2022 Out for Review<br>07 December 2022 Decision Pending<br>07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向:肿瘤;meta-analysis<br>经验分享:我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回,我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了,但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:一审三个月,没什么大问题,拖了一个月返回去,二审小修,两天返回,不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;营养<br>经验分享:with editor 一个月都已经联系编辑撤回了,等周一编辑上班回复前突然送审了就等着了,20天一审结束返修,2个审稿人都很nice,4天修回。二审一个月,刚接收!夸赞一下这个宝藏杂志,挺好的。编辑都很nice,邮件回复都很及时,沟通很愉快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224238, encodeId=b864122423872, content=审稿速度:6.0 | 投稿命中率:50.0 | 影响因子:2.9<br>经验分享:肿瘤,换主编了,审稿严格起来了,需要有一定质量的文章,审了7个月,审稿时间太长了,杯具, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Fri Jun 03 12:57:39 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2022-03-19 ms5000000220509307

    偏重的研究方向:肿瘤;meta-analysis
    经验分享:我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回,我看在我后面接受的online了……

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:药理<br>经验分享:09 January 2023<br>Manuscript Resubmitted<br>09 January 2023<br>With Journal Administrator<br>PEER REVIEW<br>28 December 2022<br>Ready to Revise<br>29 December 2022<br>Resubmission Incomplete<br>29 December 2022<br>Revised Manuscript Submitted<br>18 January 2023<br>With Editor<br>16 February 2023<br>Out for Review<br>21 February 2023<br>Decision Pending<br>24 February 2023<br>Revision Required<br>14 March 2023<br>Revision Incomplete<br>14 March 2023<br>Revised Manuscript Submitted<br>14 March 2023<br>With Journal Administrator<br>16 March 2023<br>With Editor<br>16 March 2023<br>Out for Review<br>06 April 2023<br>Decision Pending<br>09 April 2023<br>Revision Required<br>11 April 2023<br>Revision Incomplete<br>11 April 2023<br>Revised Manuscript Submitted<br>11 April 2023<br>With Journal Administrator<br>19 April 2023<br>Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor<br>14 June 2023 Out for review<br>02 August 2023 Decision Pending<br>02 August 2023 Rejected<br>等了很久,等了这个结果超级难过,本来对这个期刊抱有很大的希望,现在都开始自我怀疑了,以上的时间进度希望给大家一个参考,我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢,着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:20 August 2022 Submission Created<br>21 August 2022 Manuscript Submitted<br>21 August 2022 With Journal Administrator<br>22 August 2022 Submission Returned to Author<br>22 August 2022 Manuscript Resubmitted<br>22 August 2022 With Journal Administrator<br>24 August 2022 Ready to Revise<br>31 August 2022 Revised Manuscript Submitted<br>02 September 2022 Submission Returned to Author<br>03 September 2022 Manuscript Resubmitted<br>03 September 2022 With Journal Administrator<br>21 September 2022 With Editor<br>20 October 2022 Out for Review<br>20 October 2022 Decision Pending<br>26 October 2022 Revision Required<br>24 November 2022 Revised Manuscript Submitted<br>24 November 2022 With Journal Administrator<br>28 November 2022 With Editor<br>29 November 2022 Out for Review<br>07 December 2022 Decision Pending<br>07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向:肿瘤;meta-analysis<br>经验分享:我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回,我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了,但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:一审三个月,没什么大问题,拖了一个月返回去,二审小修,两天返回,不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;营养<br>经验分享:with editor 一个月都已经联系编辑撤回了,等周一编辑上班回复前突然送审了就等着了,20天一审结束返修,2个审稿人都很nice,4天修回。二审一个月,刚接收!夸赞一下这个宝藏杂志,挺好的。编辑都很nice,邮件回复都很及时,沟通很愉快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224238, encodeId=b864122423872, content=审稿速度:6.0 | 投稿命中率:50.0 | 影响因子:2.9<br>经验分享:肿瘤,换主编了,审稿严格起来了,需要有一定质量的文章,审了7个月,审稿时间太长了,杯具, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Fri Jun 03 12:57:39 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2022-11-11 zyl1997

    已经显示返修了,但是好几天了也没收到返修的邮件是怎么回事呀

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:药理<br>经验分享:09 January 2023<br>Manuscript Resubmitted<br>09 January 2023<br>With Journal Administrator<br>PEER REVIEW<br>28 December 2022<br>Ready to Revise<br>29 December 2022<br>Resubmission Incomplete<br>29 December 2022<br>Revised Manuscript Submitted<br>18 January 2023<br>With Editor<br>16 February 2023<br>Out for Review<br>21 February 2023<br>Decision Pending<br>24 February 2023<br>Revision Required<br>14 March 2023<br>Revision Incomplete<br>14 March 2023<br>Revised Manuscript Submitted<br>14 March 2023<br>With Journal Administrator<br>16 March 2023<br>With Editor<br>16 March 2023<br>Out for Review<br>06 April 2023<br>Decision Pending<br>09 April 2023<br>Revision Required<br>11 April 2023<br>Revision Incomplete<br>11 April 2023<br>Revised Manuscript Submitted<br>11 April 2023<br>With Journal Administrator<br>19 April 2023<br>Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor<br>14 June 2023 Out for review<br>02 August 2023 Decision Pending<br>02 August 2023 Rejected<br>等了很久,等了这个结果超级难过,本来对这个期刊抱有很大的希望,现在都开始自我怀疑了,以上的时间进度希望给大家一个参考,我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢,着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:20 August 2022 Submission Created<br>21 August 2022 Manuscript Submitted<br>21 August 2022 With Journal Administrator<br>22 August 2022 Submission Returned to Author<br>22 August 2022 Manuscript Resubmitted<br>22 August 2022 With Journal Administrator<br>24 August 2022 Ready to Revise<br>31 August 2022 Revised Manuscript Submitted<br>02 September 2022 Submission Returned to Author<br>03 September 2022 Manuscript Resubmitted<br>03 September 2022 With Journal Administrator<br>21 September 2022 With Editor<br>20 October 2022 Out for Review<br>20 October 2022 Decision Pending<br>26 October 2022 Revision Required<br>24 November 2022 Revised Manuscript Submitted<br>24 November 2022 With Journal Administrator<br>28 November 2022 With Editor<br>29 November 2022 Out for Review<br>07 December 2022 Decision Pending<br>07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向:肿瘤;meta-analysis<br>经验分享:我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回,我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了,但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:一审三个月,没什么大问题,拖了一个月返回去,二审小修,两天返回,不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;营养<br>经验分享:with editor 一个月都已经联系编辑撤回了,等周一编辑上班回复前突然送审了就等着了,20天一审结束返修,2个审稿人都很nice,4天修回。二审一个月,刚接收!夸赞一下这个宝藏杂志,挺好的。编辑都很nice,邮件回复都很及时,沟通很愉快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224238, encodeId=b864122423872, content=审稿速度:6.0 | 投稿命中率:50.0 | 影响因子:2.9<br>经验分享:肿瘤,换主编了,审稿严格起来了,需要有一定质量的文章,审了7个月,审稿时间太长了,杯具, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Fri Jun 03 12:57:39 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2020-09-11 unciawang

    审稿速度:3.0 | 投稿命中率:75.0
    经验分享:一审三个月,没什么大问题,拖了一个月返回去,二审小修,两天返回,不到两个小时接收。不要版面费。感觉好简单。

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:药理<br>经验分享:09 January 2023<br>Manuscript Resubmitted<br>09 January 2023<br>With Journal Administrator<br>PEER REVIEW<br>28 December 2022<br>Ready to Revise<br>29 December 2022<br>Resubmission Incomplete<br>29 December 2022<br>Revised Manuscript Submitted<br>18 January 2023<br>With Editor<br>16 February 2023<br>Out for Review<br>21 February 2023<br>Decision Pending<br>24 February 2023<br>Revision Required<br>14 March 2023<br>Revision Incomplete<br>14 March 2023<br>Revised Manuscript Submitted<br>14 March 2023<br>With Journal Administrator<br>16 March 2023<br>With Editor<br>16 March 2023<br>Out for Review<br>06 April 2023<br>Decision Pending<br>09 April 2023<br>Revision Required<br>11 April 2023<br>Revision Incomplete<br>11 April 2023<br>Revised Manuscript Submitted<br>11 April 2023<br>With Journal Administrator<br>19 April 2023<br>Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor<br>14 June 2023 Out for review<br>02 August 2023 Decision Pending<br>02 August 2023 Rejected<br>等了很久,等了这个结果超级难过,本来对这个期刊抱有很大的希望,现在都开始自我怀疑了,以上的时间进度希望给大家一个参考,我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢,着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:20 August 2022 Submission Created<br>21 August 2022 Manuscript Submitted<br>21 August 2022 With Journal Administrator<br>22 August 2022 Submission Returned to Author<br>22 August 2022 Manuscript Resubmitted<br>22 August 2022 With Journal Administrator<br>24 August 2022 Ready to Revise<br>31 August 2022 Revised Manuscript Submitted<br>02 September 2022 Submission Returned to Author<br>03 September 2022 Manuscript Resubmitted<br>03 September 2022 With Journal Administrator<br>21 September 2022 With Editor<br>20 October 2022 Out for Review<br>20 October 2022 Decision Pending<br>26 October 2022 Revision Required<br>24 November 2022 Revised Manuscript Submitted<br>24 November 2022 With Journal Administrator<br>28 November 2022 With Editor<br>29 November 2022 Out for Review<br>07 December 2022 Decision Pending<br>07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向:肿瘤;meta-analysis<br>经验分享:我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回,我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了,但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:一审三个月,没什么大问题,拖了一个月返回去,二审小修,两天返回,不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;营养<br>经验分享:with editor 一个月都已经联系编辑撤回了,等周一编辑上班回复前突然送审了就等着了,20天一审结束返修,2个审稿人都很nice,4天修回。二审一个月,刚接收!夸赞一下这个宝藏杂志,挺好的。编辑都很nice,邮件回复都很及时,沟通很愉快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224238, encodeId=b864122423872, content=审稿速度:6.0 | 投稿命中率:50.0 | 影响因子:2.9<br>经验分享:肿瘤,换主编了,审稿严格起来了,需要有一定质量的文章,审了7个月,审稿时间太长了,杯具, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Fri Jun 03 12:57:39 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2022-08-25 NGDZTPBCG

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤;营养
    经验分享:with editor 一个月都已经联系编辑撤回了,等周一编辑上班回复前突然送审了就等着了,20天一审结束返修,2个审稿人都很nice,4天修回。二审一个月,刚接收!夸赞一下这个宝藏杂志,挺好的。编辑都很nice,邮件回复都很及时,沟通很愉快!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2158864, encodeId=623621588644e, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:药理<br>经验分享:09 January 2023<br>Manuscript Resubmitted<br>09 January 2023<br>With Journal Administrator<br>PEER REVIEW<br>28 December 2022<br>Ready to Revise<br>29 December 2022<br>Resubmission Incomplete<br>29 December 2022<br>Revised Manuscript Submitted<br>18 January 2023<br>With Editor<br>16 February 2023<br>Out for Review<br>21 February 2023<br>Decision Pending<br>24 February 2023<br>Revision Required<br>14 March 2023<br>Revision Incomplete<br>14 March 2023<br>Revised Manuscript Submitted<br>14 March 2023<br>With Journal Administrator<br>16 March 2023<br>With Editor<br>16 March 2023<br>Out for Review<br>06 April 2023<br>Decision Pending<br>09 April 2023<br>Revision Required<br>11 April 2023<br>Revision Incomplete<br>11 April 2023<br>Revised Manuscript Submitted<br>11 April 2023<br>With Journal Administrator<br>19 April 2023<br>Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Sep 21 10:21:19 CST 2023, time=2023-09-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151054, encodeId=3795215105463, content=11 May 2023 With Editor<br>14 June 2023 Out for review<br>02 August 2023 Decision Pending<br>02 August 2023 Rejected<br>等了很久,等了这个结果超级难过,本来对这个期刊抱有很大的希望,现在都开始自我怀疑了,以上的时间进度希望给大家一个参考,我投的meta, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Aug 03 10:08:27 CST 2023, time=2023-08-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140272, encodeId=64ec21402e2e0, content=请问Out for Review多久会有消息呢,着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Thu Jun 01 09:44:16 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2146119, encodeId=8c5b214611923, content=请问meta类文章一般out for review多久会有消息呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a528242288, createdName=ms4000001156703951, createdTime=Mon Jul 03 16:19:43 CST 2023, time=2023-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2105105, encodeId=3d302105105dc, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:20 August 2022 Submission Created<br>21 August 2022 Manuscript Submitted<br>21 August 2022 With Journal Administrator<br>22 August 2022 Submission Returned to Author<br>22 August 2022 Manuscript Resubmitted<br>22 August 2022 With Journal Administrator<br>24 August 2022 Ready to Revise<br>31 August 2022 Revised Manuscript Submitted<br>02 September 2022 Submission Returned to Author<br>03 September 2022 Manuscript Resubmitted<br>03 September 2022 With Journal Administrator<br>21 September 2022 With Editor<br>20 October 2022 Out for Review<br>20 October 2022 Decision Pending<br>26 October 2022 Revision Required<br>24 November 2022 Revised Manuscript Submitted<br>24 November 2022 With Journal Administrator<br>28 November 2022 With Editor<br>29 November 2022 Out for Review<br>07 December 2022 Decision Pending<br>07 December 2022 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=60d16509363, createdName=ms1000002133818494, createdTime=Fri Dec 09 17:08:20 CST 2022, time=2022-12-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1203965, encodeId=43921203965e2, content=偏重的研究方向:肿瘤;meta-analysis<br>经验分享:我想知道接受的宝子们多久收到proof和版权书的……学校不给online不给证…… 发邮件问编辑也没人回,我看在我后面接受的online了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53645558343, createdName=ms5000000220509307, createdTime=Sat Mar 19 09:10:32 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099805, encodeId=eb40209980549, content=已经显示返修了,但是好几天了也没收到返修的邮件是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Fri Nov 11 09:55:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884539, encodeId=9d79884539d1, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:一审三个月,没什么大问题,拖了一个月返回去,二审小修,两天返回,不到两个小时接收。不要版面费。感觉好简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22a12352601, createdName=unciawang, createdTime=Fri Sep 11 14:51:14 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241022, encodeId=418a1241022b1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;营养<br>经验分享:with editor 一个月都已经联系编辑撤回了,等周一编辑上班回复前突然送审了就等着了,20天一审结束返修,2个审稿人都很nice,4天修回。二审一个月,刚接收!夸赞一下这个宝藏杂志,挺好的。编辑都很nice,邮件回复都很及时,沟通很愉快!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5862524433, createdName=NGDZTPBCG, createdTime=Thu Aug 25 21:41:07 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224238, encodeId=b864122423872, content=审稿速度:6.0 | 投稿命中率:50.0 | 影响因子:2.9<br>经验分享:肿瘤,换主编了,审稿严格起来了,需要有一定质量的文章,审了7个月,审稿时间太长了,杯具, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/07/12c20f1926191b0b222fe1cc0b5a7a85.jpg, createdBy=7bf05257864, createdName=147f69e2m39暂无昵称, createdTime=Fri Jun 03 12:57:39 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
    2022-06-03 147f69e2m39暂无昵称

    审稿速度:6.0 | 投稿命中率:50.0 | 影响因子:2.9
    经验分享:肿瘤,换主编了,审稿严格起来了,需要有一定质量的文章,审了7个月,审稿时间太长了,杯具

    1

    展开1条回复
共71条页码: 1/8页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分